DK17986D0 - Oligopeptider samt mellemprodukter og fremgangsmaade til fremstilling deraf - Google Patents
Oligopeptider samt mellemprodukter og fremgangsmaade til fremstilling derafInfo
- Publication number
- DK17986D0 DK17986D0 DK17986A DK17986A DK17986D0 DK 17986 D0 DK17986 D0 DK 17986D0 DK 17986 A DK17986 A DK 17986A DK 17986 A DK17986 A DK 17986A DK 17986 D0 DK17986 D0 DK 17986D0
- Authority
- DK
- Denmark
- Prior art keywords
- amides
- peptides
- contain
- dna sequences
- peptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57527—Calcitonin gene related peptide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Genetics & Genomics (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH18885 | 1985-01-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
DK17986D0 true DK17986D0 (da) | 1986-01-15 |
DK17986A DK17986A (da) | 1986-07-17 |
Family
ID=4181264
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK17986A DK17986A (da) | 1985-01-16 | 1986-01-15 | Oligopeptider samt mellemprodukter og fremgangsmaade til fremstilling deraf |
Country Status (12)
Country | Link |
---|---|
US (1) | US4720483A (da) |
EP (1) | EP0188400B1 (da) |
JP (1) | JPH0780908B2 (da) |
AT (1) | ATE78040T1 (da) |
CA (1) | CA1339365C (da) |
DE (1) | DE3685885D1 (da) |
DK (1) | DK17986A (da) |
ES (2) | ES8707974A1 (da) |
FI (1) | FI86547C (da) |
GR (1) | GR860081B (da) |
IE (1) | IE58190B1 (da) |
PT (1) | PT81837B (da) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5221518A (en) * | 1984-12-14 | 1993-06-22 | Mills Randell L | DNA sequencing apparatus |
GB8720115D0 (en) * | 1987-08-26 | 1987-09-30 | Cooper G J S | Treatment of diabetes mellitus |
DE3888357T2 (de) * | 1987-06-22 | 1994-09-15 | Merck & Co Inc | Cyclosporin-Derivate, die eine modifizierte Aminosäure auf Stellung 8 tragen. |
US5266561A (en) * | 1988-01-11 | 1993-11-30 | Amylin Pharmaceuticals, Inc. | Treatment of type 2 diabetes mellitus |
US5153308A (en) * | 1988-06-16 | 1992-10-06 | Teijin Limited | S-sulfonated calcitonin derivatives |
US5175145A (en) * | 1988-08-26 | 1992-12-29 | Amylin Pharmaceuticals, Inc. | Treatment of diabetes mellitus with amylin agonists |
GB8829432D0 (en) * | 1988-12-15 | 1989-02-01 | Celltech Ltd | Enzymatic process |
EP0448513A3 (en) * | 1990-03-21 | 1991-12-27 | Japat Ltd | Process for production of peptidylglycine alpha-hydroxylating monooxygenase and use thereof |
JPH06510281A (ja) * | 1991-08-08 | 1994-11-17 | アミリン・ファーマシューティカルズ,インコーポレイテッド | ペプチドアミドの製造 |
US5569604A (en) * | 1993-09-03 | 1996-10-29 | The University Of Iowa Research Foundation | Calcitonin/calcitonin gene related peptide enhancer element and associated DNA binding proteins |
US20040147022A1 (en) * | 1996-06-06 | 2004-07-29 | Baker Brenda F. | 2'-methoxy substituted oligomeric compounds and compositions for use in gene modulations |
US20040203024A1 (en) * | 1996-06-06 | 2004-10-14 | Baker Brenda F. | Modified oligonucleotides for use in RNA interference |
US7812149B2 (en) * | 1996-06-06 | 2010-10-12 | Isis Pharmaceuticals, Inc. | 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations |
US20050053976A1 (en) * | 1996-06-06 | 2005-03-10 | Baker Brenda F. | Chimeric oligomeric compounds and their use in gene modulation |
US20040171031A1 (en) * | 1996-06-06 | 2004-09-02 | Baker Brenda F. | Sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
US20050119470A1 (en) * | 1996-06-06 | 2005-06-02 | Muthiah Manoharan | Conjugated oligomeric compounds and their use in gene modulation |
US5898031A (en) * | 1996-06-06 | 1999-04-27 | Isis Pharmaceuticals, Inc. | Oligoribonucleotides for cleaving RNA |
US20050042647A1 (en) * | 1996-06-06 | 2005-02-24 | Baker Brenda F. | Phosphorous-linked oligomeric compounds and their use in gene modulation |
US9096636B2 (en) * | 1996-06-06 | 2015-08-04 | Isis Pharmaceuticals, Inc. | Chimeric oligomeric compounds and their use in gene modulation |
AU725954B2 (en) * | 1996-08-15 | 2000-10-26 | Board Of Trustees Of Southern Illinois University, The | Enhancement of antimicrobial peptide activity by metal ions |
DE19652033A1 (de) * | 1996-12-13 | 1998-06-18 | Irmgard Dr Med Guertner | Neuropeptid (CGRP) als Modulator zur Zelldifferenzierung und Proliferation |
AU2003291755A1 (en) * | 2002-11-05 | 2004-06-07 | Isis Pharmaceuticals, Inc. | Oligomers comprising modified bases for binding cytosine and uracil or thymine and their use |
US20060241072A1 (en) * | 2003-06-20 | 2006-10-26 | Isis Pharmaceuticals, Inc. | Oligomeric compounds for use in gene modulation |
CA2552677A1 (en) * | 2004-01-13 | 2005-07-28 | Vasogenix Pharmaceuticals, Inc. | Controlled release cgrp delivery composition for cardiovascular and renal indications |
EP1703916A2 (en) * | 2004-01-13 | 2006-09-27 | Vasogenix Pharmaceuticals, Inc. | Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same |
CA2552757A1 (en) * | 2004-01-13 | 2005-08-04 | Vasogenix Pharmaceuticals, Inc. | Methods of using cgrp for cardiovascular and renal indications |
US8569474B2 (en) * | 2004-03-09 | 2013-10-29 | Isis Pharmaceuticals, Inc. | Double stranded constructs comprising one or more short strands hybridized to a longer strand |
US8394947B2 (en) * | 2004-06-03 | 2013-03-12 | Isis Pharmaceuticals, Inc. | Positionally modified siRNA constructs |
JP2008501693A (ja) * | 2004-06-03 | 2008-01-24 | アイシス ファーマシューティカルズ、インク. | 遺伝子調節で使用するための個別に調節された鎖を有する二本鎖組成物 |
US7884086B2 (en) * | 2004-09-08 | 2011-02-08 | Isis Pharmaceuticals, Inc. | Conjugates for use in hepatocyte free uptake assays |
US8168592B2 (en) * | 2005-10-21 | 2012-05-01 | Amgen Inc. | CGRP peptide antagonists and conjugates |
JP4884193B2 (ja) * | 2006-12-15 | 2012-02-29 | ヤマハ発動機株式会社 | 船舶 |
WO2011051312A1 (en) | 2009-10-30 | 2011-05-05 | Novo Nordisk A/S | Derivatives of cgrp |
MY184409A (en) * | 2011-08-22 | 2021-04-01 | Suganit Systems Inc | Production of bio-butanol and related products |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1985000043A1 (en) * | 1983-06-15 | 1985-01-03 | Kingdon Craig R | Peptides, pharmaceutical compositions, genes, vectors, host organisms, processes for their production and diagnostic reagents |
US4530838A (en) * | 1983-07-08 | 1985-07-23 | The Salk Institute For Biological Studies | Synthetic calcitonin-gene-related peptides for lowering blood pressure or gastric acid secretion in mammals |
GB8327346D0 (en) * | 1983-10-12 | 1983-11-16 | Morris H R | Peptide |
US4549986A (en) * | 1983-12-23 | 1985-10-29 | The Salk Institute For Biological Studies | Human CGRP |
-
1986
- 1986-01-10 EP EP86810007A patent/EP0188400B1/de not_active Expired - Lifetime
- 1986-01-10 AT AT86810007T patent/ATE78040T1/de not_active IP Right Cessation
- 1986-01-10 DE DE8686810007T patent/DE3685885D1/de not_active Expired - Lifetime
- 1986-01-13 FI FI860153A patent/FI86547C/fi not_active IP Right Cessation
- 1986-01-14 PT PT81837A patent/PT81837B/pt not_active IP Right Cessation
- 1986-01-14 JP JP61006159A patent/JPH0780908B2/ja not_active Expired - Lifetime
- 1986-01-14 CA CA000499545A patent/CA1339365C/en not_active Expired - Lifetime
- 1986-01-14 GR GR860081A patent/GR860081B/el unknown
- 1986-01-15 ES ES550911A patent/ES8707974A1/es not_active Expired
- 1986-01-15 US US06/819,168 patent/US4720483A/en not_active Expired - Lifetime
- 1986-01-15 IE IE11686A patent/IE58190B1/en not_active IP Right Cessation
- 1986-01-15 DK DK17986A patent/DK17986A/da not_active Application Discontinuation
-
1987
- 1987-01-14 ES ES557315A patent/ES8802161A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
JPH0780908B2 (ja) | 1995-08-30 |
DE3685885D1 (de) | 1992-08-13 |
GR860081B (en) | 1986-04-29 |
US4720483A (en) | 1988-01-19 |
IE860116L (en) | 1986-07-16 |
FI86547B (fi) | 1992-05-29 |
ES557315A0 (es) | 1988-04-01 |
DK17986A (da) | 1986-07-17 |
JPS61172899A (ja) | 1986-08-04 |
ES8802161A1 (es) | 1988-04-01 |
ATE78040T1 (de) | 1992-07-15 |
FI860153A0 (fi) | 1986-01-13 |
EP0188400A3 (en) | 1988-08-31 |
ES550911A0 (es) | 1987-09-01 |
FI86547C (fi) | 1992-09-10 |
FI860153A (fi) | 1986-07-17 |
PT81837A (en) | 1986-02-01 |
ES8707974A1 (es) | 1987-09-01 |
EP0188400A2 (de) | 1986-07-23 |
PT81837B (pt) | 1988-05-27 |
CA1339365C (en) | 1997-08-26 |
IE58190B1 (en) | 1993-07-28 |
EP0188400B1 (de) | 1992-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK17986D0 (da) | Oligopeptider samt mellemprodukter og fremgangsmaade til fremstilling deraf | |
FI953658A (fi) | Stabiileja bakterisidisia/läpäisevyyttä parantavia proteiinituotteita ja näitä sisältäviä farmaseuttisia koostumuksia | |
HUP0004560A2 (hu) | Törést gyógyító PTHrP analógok | |
DE3856265D1 (de) | Varianten des pankreatischen Rinder-Trypsininhibitors, deren Herstellung und Verwendung | |
DK382786D0 (da) | Overfladeaktivt rekombinant-alveolarprotein | |
DE3688324D1 (de) | Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel. | |
ATE163651T1 (de) | Neues menschliches, rekombinantes interferon gamma | |
NZ335633A (en) | Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases | |
DE59410423D1 (de) | Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose | |
DK595187A (da) | Minactivin og fremgangsmaade til fremstilling deraf | |
ATE452903T1 (de) | Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten | |
DK0423326T3 (da) | Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHS | Application shelved for other reasons than non-payment |